We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
31 hedge funds and large institutions have $6.91M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
48% more call options, than puts
Call options by funds: $108K | Put options by funds: $73K
29% more capital invested
Capital invested by funds: $5.35M → $6.91M (+$1.56M)
11% less funds holding
Funds holding: 35 → 31 (-4)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
5
Reduced
7
Closed
5
Calls
$108K
Puts
$73K
Net Calls
+$35K
Net Calls Change
+$74K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.33M |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$195K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.56K |
| 5 |
Morgan Stanley
New York
|
+$1.28K |
